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m103668 ActualSamaDayDiachargeAfterSuccessfulPTCA:OutcomeoftheOUTCLAS-PilotStudy
T. Slagboom, F. Kiemeney, G. Laarman, R. van der Wieken. Arrrsterdarrr
Department of Interventionai Cardiology (ADIC)-OLVG,Amsterdam, The
Netherlands
The aim of the OUTCLAS WPatiOnt Coronary Low-Profile An9ioPkiatY
study), a large proapactive single center atudy is to test the safety and
feasibility of actual same day discharge after PTCA in a low-risk patient
group, based on a setof previously tested clinical and angiographic param-
aterdpredietore of acute occlusion in the first 24 hours. Patients selected
for elective balloon angioplasty or stent implantation for single or multivessel
disease, for stable and unatable angina, were included.
PTCA was performed with 6 French Catheter equipment and under a
low dose of Heparin (5000 W for PTCA, 10.OW for stent), using the radial
attery approach. Immediate post-procedural sheath removal, together with
the former measures, are imperative to facilitate eerlyambulation, necessary
for same day discharge.
in 4 months 159 patients were included. 106 patients (67%) were selacted
for same day discharge baaed on our predefine parameters. 42 (40%)
patients in the outpatient group received one or more intracoronary stents
either elective orforsuboptirnal PTCA result. 24 hourtelephonefollow upwas
uneventful in all patients with regard to cardiac and vascular complications.
53 patients (33Yo) were selected for 24-hour hospital atay, most of them on
continuous haperin infusion. In 9 patients (17Yo)a stent wee implanted. Three
r)atients had abrupt vesael closure, <1 hour after successful PTCA. 1 patient
sustained a TIA.
Conclusion: Selected patients can be safely discharged on the same day
that transredial PTCA is performed, with minimal risk for cardiac or vascular
eomcdieationa.if a aet of determinants for acute vessel closura is applied and
if adbquate ~theter equipment ia used.
11036-89I CompariaOnofCiinka,and~conomic~utcomea
of Radialva. FemoralAccesaSiteainCoronary
Stenting
J.T. Mann, G. Cubeddu, J. Bowen, M.E. Arrowoed, J.E. Schneider. Wake
Heafl Centec Raleigh, NC, USA
Clinical and economic outcomes were retrospectively evaluated in 719 pa-
tients (pte) who underwent coronary stenting using the radial (R) and femoral
(F)acoesssitesbetween 12/94-W6. Baseline demographicswere similarfor
tnth groups. Primary auccess rate, number of pts managed with Ticlicf/ASA
alone, vaacular Complications (VC), poet procedure (PP) and total hospital
(TH) length of atay (LOS), oath lab charge (CLC) and TH charge (THC) were
compared. Results are as follows:
Femoral Radial P Value
Patients, n 413 Sos
Primary success, “A 9s 95 NS
TIcIWASA,“A 68 71 NS
Vc, Y. 5 0.3 <0.01
PPLOS,days+ SEM 3.2+ 0.13 2.2* 0.12 <0.01
THLOS, days+ SEM 5.5 l 0.20 3.s+ 0.20 <0.01
CLC,$ + SEM 7,069* 115 6,563+ 116 <0.01
THC,$ + SEM 24,218+ 5S0 19,675+ 520 <0.01
Cone/usiorr:1)Coronaw stenting can be performed from the radial ap-
proach aa successfully as the femoral approach with fewer vascular impli-
cations. 2) There waa a 19% reduction in hospital charge in the transradial
group due to significantly shorter hospital length of stay and lower cath lab
charges.
11036-90]*venFmnCh(7F)Transradia, APProachA,,~~a
WidespreadUseof CoronaryStentingWithLow
ComplicationRateInSelactedPatienta
C. Karam, C. Lohbeyre, J. Fajadet, J.-C. Leborde, C. Jordan,
B. Caaeagneau, J.-P. Laurent, J. Marco. Cliniqua PasteuL Toulouse,France
Transradial (TR) 6 F is a safe approach for PTCA, associated with an early
discharge and a low complication rate. Some stents (S) cannot be used
through 6 F guiding Catheters. In patients (Pts) with strong radial pulse and
favorable Allen test, 7 F TR approach can be performed and allows wider
S choice. Between May and August 1996, 161 Pts underwent PTCA via 7
F TR approach, with successful vascular access in 174 (97.1%), 145 men
and 29 women, mean age 64.5 + 10.5 yeare, with unstable angina (40%),
arable angina (4WO) or reeent Ml (12%). PTCA was successful in 97.7%
of the Pts, of whom 22% had 2 vessels dilated during the proeadure. The
dilated vessel waa either LAD (36Yo), LCX(25Yo),RCA (33%) or graft (6Yo).
JACC February 1997
Mean lesion length was 13.9 + 8 mm. ACCIAHA lesion type waa A in 12%,
B in 66% and C in 22%. Stenting rate wee 74% with a mean of 1.4 SPt.
We used Gianturco-Roubin (40%), RX Multilink (22%), NIR S (II%), Magic
Wallstent (7%), Palmaz-Schatz (7%), Insb?nt(4%) and other S in 9%. Final S
diameter was 3.39 + 0.36 mm. Vascular access complications consisted of
one subclavian dissection and one forearm hematoma. We compared major
events during hospital stay with those of 179 Pts undergoing PTCA at the
same period via 6 F TR approach, and we did not obsewe any significant
difference between both groups.
Success sccess Death CABG Ml SAT “/.Vaac
% % % % % comnllc
7F 97.1 1,1 0.5 0.5 0 1,1
6F 9s.s 0.5 0 0.5 0,5 0.5
0 NS NS NS NS NS NS
Seven F TR approach is feasible with same in-hospital resulta as 6 F but
allows wider S choice in type and diameter.
11036-91/ ThenewlnFlowStent:CliniCa,andAngiOgraphiC
Reaulta
E. Alt, S. Elezi, E.-M. Zitzmann, J. Hausleiter, A. Rybnikar, A. Schbmig. L
Med. Klinik, K/inikum rechts der Lsarand Deutsches Herzzentrum,
German& T%hnische Univereit~t Miirrchen, Germany
Stent designs favoring good vascular support are necessary to reduce recoil
but confer decreased flexibility, limiting the use in complex Coronarylesions.
The balloon expandable stainless steel InFlow stent is a novel laser-cut
tube stent consisting of linked, circumferential sinusoidal struts with oval
strut cross sections. To assess the utility of this advanced stent design, 336
stents of various length (242 = 7 mm, 54 = 9 mm, 35 = 11 mm, 7 = 15
mm) were implanted in 164 Ieaions (8 LM, 74 LAD, 70 RCA, 32 LCX) in
108 patients. 14% type A, 13% Bl, 38% B2, 35% C. The mean length of
stented segments per patient was 25.2 mm. 22 patients were stentsd in acute
myocardial infarction. Stents were manually folded onto standard angioplaaty
balloons. Patients were treated with 100 mg aspirin and 250mg ticlopidine
bid. Angiographic reaults were analyzed by QCA.
Results: Stent deployment was successful in 1641165lesions (99.5%).
Mesn maslmumballoonpressurewss: 11.S* 1.7atm.
Minimallumendiameter (mm) 0.76+c 0.4S
pereentstenosis (%) 74.5* 14.7
balloon-to-vesselratio 1.01 i 0.09
refersnce diameter poststsnt (mm) 3,05+ 0.5
minimalIumandiameter poststent (mm) 2.s4+ 0.49
residualstenosispoststent (o/o) 6.8 *4.1
acute recoil(%) 4,7* 3.4
At 30 daya follow-up there ware two acute stent thromboees, one restenoeia
needing re-PTCAandonemajor groin hematoma requiring ultrasound-guided
manualcompression. There were nodeatha, myocardial infarctions orCABG.
Conclusion: The new InFlow stent exhibits low recoil while retaining
high procedural suceeas aven with eompticatsd Ieaions. With combined
antiplatelet therapy, it provides favorable clinical and angiogrsphic reaulta
without the need for high pressure balloons.
m103692 TheNewGianturco-RoubinCoronaryStentisanImprovedTherapyforAbruptandThreatened
ClosureSyndroma
C.D. O’Shaughnessy, J.J. Popma, L.S. Dean, E.T.A. Fry, J.P. Carrozza,
W.D. Knopf, D.J. Kereiakea, B.S. George, M.A. Thompson, J.A. Brinker,
A.E. Raizner, M.B. Leon. Nor?hOhio Heart Centec E/yrfa, OH, USA
To address the limitations of previous Coronary stent designa for the treat-
ment of abrupthhreatened closure (AC), the new Gianturco-Roubin (GRII’”)
stent has a more flexible geometry, improved scaffolding, radio-opaque end-
markers, and variable lengths (20 mm and 40 mm). Thus far, the firat 275
consecutive patients have been analyzed from 23 centers in the GR117”AC
registry. Earlier treatment of dissections was emphasized and the majority of
pts (91%) had thrsatened(TIMl > O)closure syndrome. Lesions treated were
extremely complex with B2/C class 83%, proximal tortuosity 73%, diffuse dia-
ease 58% (lesion length 18.7 + 12.0 mm), bifurcation 27%, and > type B
diesections54%. Nevertheless, successful (GRllm), placement waaachievsd
in 273/275 (99.3%) pte (average 1.7 StOntSper pt; 34% 40 mm stente) with
complete resolution of diaseetions in 69%, resumption of TIMI 3 flow in 96%,
and final % diameter stenosis 2.47.. Despite ASA plus ticlopidine treatment
in all pts (some with additional anticoagulation), aubacute stent thrombosis
(SAT)occurred in 12 (4.4%) pts; 6 events in the first24 hours. Major adverae
